{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:14:07Z","timestamp":1765289647164,"version":"3.46.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study was partially supported by the Special Project of Central Government for Local Science and Technology Development of Hubei Province","award":["2020ZYYD006"],"award-info":[{"award-number":["2020ZYYD006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1245\/s10434-025-18237-1","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T12:10:20Z","timestamp":1757506220000},"page":"518-529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Number of Examined Lymph Nodes in the Highest Quartile Enhances Staging and Prognosis for Patients with Esophageal Cancer Receiving Neoadjuvant Therapy"],"prefix":"10.1245","volume":"33","author":[{"given":"Lingling","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengkai","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongshun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"18237_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin."},{"key":"18237_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","volume":"16","author":"J Shapiro","year":"2015","unstructured":"Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. CROSS Study Group. Lancet Oncol. 2015;16:1090\u20138.","journal-title":"Lancet Oncol."},{"key":"18237_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","volume":"156","author":"H Yang","year":"2021","unstructured":"Yang H, Liu H, Chen Y, et al. Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial. JAMA Surg. 2021;156:721\u20139.","journal-title":"JAMA Surg."},{"key":"18237_CR4","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.20.03614","volume":"39","author":"BM Eyck","year":"2021","unstructured":"Eyck BM, van Lanschot JJB, Hulshof MCCM, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol. 2021;39:1995\u20132004.","journal-title":"J Clin Oncol."},{"key":"18237_CR5","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1200\/JCO.2006.10.4760","volume":"25","author":"DP Kelsen","year":"2007","unstructured":"Kelsen DP, Winter KA, Gunderson LL, et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol. 2007;25:3719\u201325.","journal-title":"J Clin Oncol."},{"key":"18237_CR6","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1200\/JCO.2009.22.2083","volume":"27","author":"WH Allum","year":"2009","unstructured":"Allum WH, Stenning SP, Bancewicz J, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27:5062\u20137.","journal-title":"J Clin Oncol."},{"key":"18237_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijsu.2016.12.035","volume":"38","author":"Y Huang","year":"2017","unstructured":"Huang Y, Wang H, Luo G, et al. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinoma. Int J Surg. 2017;38:41\u20137.","journal-title":"Int J Surg."},{"key":"18237_CR8","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S2468-1253(23)00243-1","volume":"8","author":"JV Reynolds","year":"2023","unstructured":"Reynolds JV, Preston SR, O\u2019Neill B, et al. Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial. Lancet Gastroenterol Hepatol. 2023;8:1015\u201327.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"18237_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12885-024-11886-7","volume":"24","author":"RD Lu","year":"2024","unstructured":"Lu RD, Wei ZD, Liu YX, et al. Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma. BMC Cancer. 2024;24:177.","journal-title":"BMC Cancer."},{"key":"18237_CR10","doi-asserted-by":"publisher","first-page":"doac082","DOI":"10.1093\/dote\/doac082","volume":"36","author":"D Jiang","year":"2023","unstructured":"Jiang D, Liu XB, Xing WQ, et al. Survival impact of the number of lymph nodes dissection in patients receiving neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Dis Esophagus. 2023;36:doac082.","journal-title":"Dis Esophagus."},{"key":"18237_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/SLA.0000000000004479","volume":"276","author":"S Sihag","year":"2022","unstructured":"Sihag S, Nobel T, Hsu M, et al. A more extensive lymphadenectomy enhances survival after neoadjuvant chemoradiotherapy in locally advanced esophageal adenocarcinoma. Ann Surg. 2022;276(2):312\u20137.","journal-title":"Ann Surg."},{"key":"18237_CR12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/SLA.0000000000000965","volume":"260","author":"AK Talsma","year":"2014","unstructured":"Talsma AK, Shapiro J, Looman CW, et al. Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg. 2014;260(5):786\u201392 (discussion 792\u20133).","journal-title":"Ann Surg."},{"key":"18237_CR13","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1245\/s10434-013-2988-4","volume":"20","author":"R Shridhar","year":"2013","unstructured":"Shridhar R, Hoffe SE, Almhanna K, et al. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy. Ann Surg Oncol. 2013;20:3038\u201343.","journal-title":"Ann Surg Oncol."},{"key":"18237_CR14","doi-asserted-by":"publisher","first-page":"e1239","DOI":"10.1097\/SLA.0000000000005450","volume":"277","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Cao Y, Zhang J, et al. Lymph node ratio improves prediction of overall survival in esophageal cancer patients receiving neoadjuvant chemoradiotherapy: a National Cancer Database analysis. Ann Surg. 2023;277:e1239\u201346.","journal-title":"Ann Surg."},{"key":"18237_CR15","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1245\/s10434-021-10240-6","volume":"28","author":"K Kano","year":"2021","unstructured":"Kano K, Yamada T, Komori K, et al. The prognostic value of lymph node ratio in locally advanced esophageal cancer patients who received neoadjuvant chemotherapy. Ann Surg Oncol. 2021;28:8464\u201372.","journal-title":"Ann Surg Oncol."},{"key":"18237_CR16","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/jso.25888","volume":"121","author":"G Ye","year":"2020","unstructured":"Ye G, Chen Z, Wang L, et al. Log odds of positive lymph nodes predicts survival in patients treated with neoadjuvant therapy followed by esophagectomy. J Surg Oncol. 2020;121:1074\u201383.","journal-title":"J Surg Oncol."},{"key":"18237_CR17","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s11605-015-2821-4","volume":"19","author":"RA Luna","year":"2015","unstructured":"Luna RA, Dolan JP, Diggs BS, et al. Lymph node harvest during esophagectomy is not influenced by use of neoadjuvant therapy or clinical disease stage. J Gastrointest Surg. 2015;19:1201\u20137.","journal-title":"J Gastrointest Surg."},{"key":"18237_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/SLA.0b013e31815aaadf","volume":"247","author":"C Mariette","year":"2008","unstructured":"Mariette C, Piessen G, Briez N, et al. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg. 2008;247:365\u201371.","journal-title":"Ann Surg."},{"key":"18237_CR19","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1245\/s10434-019-07870-2","volume":"27","author":"JC Yeung","year":"2020","unstructured":"Yeung JC, Bains MS, Barbetta A, et al. How many nodes need to be removed to make esophagectomy an adequate cancer operation, and does the number change when a patient has chemoradiotherapy before surgery? Ann Surg Oncol. 2020;27:1227\u201332.","journal-title":"Ann Surg Oncol."},{"key":"18237_CR20","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1245\/s10434-018-6396-7","volume":"25","author":"LR van der Werf","year":"2018","unstructured":"van der Werf LR, Dikken JL, van Berge Henegouwen MI, et al. A population-based study on lymph node retrieval in patients with esophageal cancer: results from the Dutch Upper Gastrointestinal Cancer Audit. Ann Surg Oncol. 2018;25:1211\u201320.","journal-title":"Ann Surg Oncol."},{"key":"18237_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.athoracsur.2016.08.010","volume":"103","author":"P Samson","year":"2017","unstructured":"Samson P, Puri V, Broderick S, et al. Extent of lymphadenectomy is associated with improved overall survival after esophagectomy with or without induction therapy. Ann Thorac Surg. 2017;103:406\u201315.","journal-title":"Ann Thorac Surg."},{"key":"18237_CR22","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1245\/s10434-020-08578-4","volume":"27","author":"CJR Schlick","year":"2020","unstructured":"Schlick CJR, Khorfan R, Odell DD, et al. Adequate lymphadenectomy as a quality measure in esophageal cancer: is there an association with treatment approach? Ann Surg Oncol. 2020;27:4443\u201356.","journal-title":"Ann Surg Oncol."},{"key":"18237_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13019-021-01728-z","volume":"16","author":"RE Merritt","year":"2021","unstructured":"Merritt RE, Kneuertz PJ, Abdel-Rasoul M, et al. Comparative analysis of long-term oncologic outcomes for minimally invasive and open Ivor Lewis esophagectomy after neoadjuvant chemoradiation: a propensity score-matched observational study. J Cardiothorac Surg. 2021;16:347.","journal-title":"J Cardiothorac Surg."},{"key":"18237_CR24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.athoracsur.2015.09.062","volume":"101","author":"LF Tapias","year":"2016","unstructured":"Tapias LF, Mathisen DJ, Wright CD, et al. Outcomes with open and minimally invasive ivor lewis esophagectomy after neoadjuvant therapy. Ann Thorac Surg. 2016;101:1097\u2013103.","journal-title":"Ann Thorac Surg."},{"key":"18237_CR25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.athoracsur.2020.09.022","volume":"112","author":"WA Song","year":"2021","unstructured":"Song WA, Fan BS, Di SY, et al. Three-field lymphadenectomy in minimally invasive esophagectomy for squamous cell carcinoma. Ann Thorac Surg. 2021;112:928\u201334.","journal-title":"Ann Thorac Surg."},{"key":"18237_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1245\/s10434-018-6946-z","volume":"26","author":"H Miyata","year":"2019","unstructured":"Miyata H, Sugimura K, Yamasaki M, et al. Clinical impact of the location of lymph node metastases after neoadjuvant chemotherapy for middle and lower thoracic esophageal cancer. Ann Surg Oncol. 2019;26:200\u20138.","journal-title":"Ann Surg Oncol."},{"key":"18237_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1245\/s10434-009-0819-4","volume":"17","author":"N Solomon","year":"2010","unstructured":"Solomon N, Zhuge Y, Cheung M, et al. The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma. Ann Surg Oncol. 2010;17:791\u2013803.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18237-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18237-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18237-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:09:53Z","timestamp":1765289393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18237-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["18237"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18237-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"We retrospectively collected information on patient consultations from the hospital health care system, and this study posed no risk to patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"After reviewed by the Ethical Committee of Renmin Hospital of Wuhan University (WDRY2023-K058), our study was approved exemption from signing informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}}]}}